Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ptsc email on their stock buy back efforts...

ptsc email on their stock buy back efforts...

posted on May 31, 2006 12:35PM
My apologies on the late response.

Here`s how the stock buyback will be implemented.

From the April 24th press release.

``The stock buyback plan adopted by the Board of Directors calls for management to use not less than 10 percent of future licensing revenue distributions received by the Company to purchase shares of our stock on the open market in a manner consistent with applicable securities laws and regulations,`` said David H. Pohl, Chairman and CEO of Patriot Scientific. ``These buybacks are, of course, subject to the Company determining at the time licensing revenue distributions are received that such action is prudent based upon market conditions and sound financial management considerations. Repurchased shares will be placed in our treasury as a resource available for possible future use,``. Pohl explained.

Regards,

Ken AuYeung, Hawk Associates Inc

Share
New Message
Please login to post a reply